2026 Sponsors

Ab Initio Pharma is a pharmaceutical formulation R&D and GMP Manufacturing company based in Sydney, Australia. The company provides innovators across Australia and globally with a flexible platform to rapidly translate bench-top discoveries to clinical trial products and fully-fledged commercial pharmaceuticals.

The awarded speaker will receive a sponsorship package valued at $20,000 to access pharmaceutical development services, including formulation, analytical R&D support and preclinical facilities.

At FPA Patent Attorneys focus on two areas of intellectual property – patents and designs. They are the only Intellectual Property firm in Australia with this degree of specialisation. They use their expertise to bring insights, solve problems and co-create custom solutions.

This year, an outstanding pitch will be supported by a speaker prize valued at $1,000.


TIA invests in translational research infrastructure to enable seamless access to expertise and services vital to translate research discoveries into human health impacts. Their investment in people and capital lowers the financial bar to access expertise for all translational researchers, including academics, clinicians, medical research institutes and small-medium enterprises.


MCE is dedicated to providing global customers with a novel and comprehensive selection of high-quality active small-molecule compounds. They provide reagents for key disease research areas such as cancer, neuroscience, and immunology.

John Morris is a leading supplier of research, laboratory and analysis equipment for over 70 years.